Revium Rx (RVRC) Shares Outstanding (2024 - 2025)

Revium Rx recorded quarterly Shares Outstanding of $60.7 million in Q4 2025, little changed quarter-over-quarter from $60.7 million in Q4 2024, and little changed year-over-year from $60.7 million in Q4 2024.

Revium Rx's Shares Outstanding history runs 2 years deep, the most recent figure standing at $60.7 million for Q4 2025.

  • In Q4 2025, Shares Outstanding changed 0.0% year-over-year to $60.7 million; the TTM figure through Dec 2025 stood at $60.7 million (changed 0.0% YoY), while the FY2025 annual figure was $60.7 million, changed 0.0% from the prior year.
  • Shares Outstanding came in at $60.7 million for Q4 2025 at Revium Rx, roughly flat from $60.7 million in the prior quarter.
  • In the past five years, Shares Outstanding ranged from a high of $60.7 million in Q4 2024 to a low of $60.7 million in Q4 2024.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shares (Qtr)
1 Veeva Systems 30.85 Bn 24.28 Bn 622.47 Mn 163.78 Mn
2 BrightSpring Health Services 12.29 Bn 11.41 Bn 482.22 Mn 193.21 Mn
3 Healthequity 7.80 Bn 7.48 Bn 256.31 Mn 83.93 Mn
4 Hinge Health 4.82 Bn 4.51 Bn 154.23 Mn 77.30 Mn
5 Doximity 4.21 Bn 3.46 Bn 125.97 Mn 183.06 Mn
6 Waystar Holding 4.18 Bn 4.03 Bn 268.04 Mn 191.69 Mn
7 10x Genomics 3.78 Bn 3.24 Bn 106.18 Mn 128.99 Mn
8 Privia Health 2.65 Bn 2.28 Bn 595.71 Mn 125.69 Mn
9 Omnicell 1.95 Bn 1.78 Bn 140.36 Mn 45.48 Mn
10 Revium Rx - - - 60.73 Mn

Historic Data

Download Data 🔒
DateValue
Dec 31, 2025 60.73 Mn
Dec 31, 2025 60.73 Mn
Dec 31, 2025 60.73 Mn
Dec 31, 2025 60.73 Mn
Dec 31, 2025 60.73 Mn
Dec 31, 2025 60.73 Mn
Dec 31, 2025 60.73 Mn
Dec 31, 2025 60.73 Mn
Dec 31, 2024 60.73 Mn
Dec 31, 2024 60.73 Mn
Dec 31, 2024 60.73 Mn
Dec 31, 2024 60.73 Mn
Dec 31, 2024 60.73 Mn
Dec 31, 2024 60.73 Mn
Dec 31, 2024 60.73 Mn
Dec 31, 2024 60.73 Mn